SCHEMBL23484456

SCHEMBL23484456

CC(C)c1cc(F)c(C2CCCCCCCCCC2)cc1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.40
HSP90AB1 P08238 2/20 0.40
NUDT1 P36639 1/20 0.38
BACE1 P56817 1/20 0.38
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 2/20 0.35
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
APP P05067 1/20 0.33
TRPA1 O75762 1/20 0.33
CHRM1 P11229 1/20 0.33
SLC6A2 P23975 1/20 0.33
ADRA1A P35348 1/20 0.33
HTR2B P41595 1/20 0.33
PTGDR2 Q9Y5Y4 3/20 0.33
FEN1 P39748 1/20 0.33
PTGDR Q13258 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22214041 1.00 HSP90AA1 (0.40) HSP90AA1HSP90AB1NUDT1BACE1CYP1A2
SCHEMBL22393944 1.00 HSP90AA1 (0.40) HSP90AA1HSP90AB1NUDT1BACE1CYP1A2
SCHEMBL22295956 1.00 HSP90AA1 (0.40) HSP90AA1HSP90AB1NUDT1BACE1CYP1A2
SCHEMBL23425688 0.88 NUDT1 (0.36) HSP90AA1HSP90AB1NUDT1BACE1APP
SCHEMBL24961937 0.87 PTGS1 (0.35) HSP90AA1HSP90AB1CYP1A2CYP2D6MAPK1
SCHEMBL24403162 0.85 RORC (0.41) HSP90AA1NUDT1BACE1APPPTGDR2
SCHEMBL22393853 0.85 RORC (0.41) HSP90AA1NUDT1BACE1APPPTGDR2
SCHEMBL16014088 0.81 NUDT1 (0.45) HSP90AA1NUDT1BACE1PTGDR2FEN1
SCHEMBL16736870 0.79 NUDT1 (0.39) HSP90AA1HSP90AB1NUDT1BACE1GABRA1
SCHEMBL1244494 0.79 LMNA (0.47) HSP90AA1HSP90AB1NUDT1BACE1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11326165-B1 Methods and compositions for modulating splicing SKYHAWK THERAPEUTICS, INC. (US) 2022-05-10 US disclosed
US-11091475-B2 Methods and compositions for modulating splicing SKYHAWK THERAPEUTICS, INC. (US) 2021-08-17 US disclosed
US-20210171519-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11326165-B1 Methods and compositions for modulating splicing RBM17, SF3B1, SNRPA1 HSP90AA1 2130/4885HSP90AB1 1650/4885NUDT1 1330/4885
US-20210171519-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SNRPA1 HSP90AA1 2130/4885HSP90AB1 1650/4885NUDT1 1330/4885
US-11091475-B2 Methods and compositions for modulating splicing RBM17, SF3B1, SNRPA1 HSP90AA1 2130/4885HSP90AB1 1650/4885NUDT1 1330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.